Regression of paclitaxel-induced maculopathy with oral acetazolamide. [electronic resource]
Producer: 20120518Description: 463-4 p. digitalISSN:- 1435-702X
- Acetazolamide -- therapeutic use
- Administration, Oral
- Antineoplastic Agents, Phytogenic -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carbonic Anhydrase Inhibitors -- therapeutic use
- Female
- Humans
- Lymphatic Metastasis
- Macular Edema -- chemically induced
- Melanoma -- drug therapy
- Middle Aged
- Paclitaxel -- adverse effects
- Skin Neoplasms -- drug therapy
- Tomography, Optical Coherence
- Vision Disorders -- chemically induced
- Visual Acuity
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.